Cyrano Therapeutics
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell.
cyranotherapeutics.comCompany Details
Founded
- 2014
Employees
- Between 5 - 10 employees
Raised
- $21,800,000
Public
- No
Acquired
- No
CEO
Rick Geoffrion
Founders
- Rick GeoffrionRobert Henkin
Company Collections
These are collections Cyrano Therapeutics is a part of. Click on the collection name to view similar companies.